251 related articles for article (PubMed ID: 16219322)
1. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.
Lee TW; Cherney MM; Huitema C; Liu J; James KE; Powers JC; Eltis LD; James MN
J Mol Biol; 2005 Nov; 353(5):1137-51. PubMed ID: 16219322
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptide epoxide to SARS coronavirus main peptidase.
Lee TW; Cherney MM; Liu J; James KE; Powers JC; Eltis LD; James MN
J Mol Biol; 2007 Feb; 366(3):916-32. PubMed ID: 17196984
[TBL] [Abstract][Full Text] [Related]
3. Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease.
Zhu L; George S; Schmidt MF; Al-Gharabli SI; Rademann J; Hilgenfeld R
Antiviral Res; 2011 Nov; 92(2):204-12. PubMed ID: 21854807
[TBL] [Abstract][Full Text] [Related]
4. A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase.
Yin J; Niu C; Cherney MM; Zhang J; Huitema C; Eltis LD; Vederas JC; James MN
J Mol Biol; 2007 Aug; 371(4):1060-74. PubMed ID: 17599357
[TBL] [Abstract][Full Text] [Related]
5. Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.
Lu IL; Mahindroo N; Liang PH; Peng YH; Kuo CJ; Tsai KC; Hsieh HP; Chao YS; Wu SY
J Med Chem; 2006 Aug; 49(17):5154-61. PubMed ID: 16913704
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease.
Wu CG; Cheng SC; Chen SC; Li JY; Fang YH; Chen YH; Chou CY
Acta Crystallogr D Biol Crystallogr; 2013 May; 69(Pt 5):747-55. PubMed ID: 23633583
[TBL] [Abstract][Full Text] [Related]
7. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
Vuong W; Khan MB; Fischer C; Arutyunova E; Lamer T; Shields J; Saffran HA; McKay RT; van Belkum MJ; Joyce MA; Young HS; Tyrrell DL; Vederas JC; Lemieux MJ
Nat Commun; 2020 Aug; 11(1):4282. PubMed ID: 32855413
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the development of SARS 3CL protease inhibitors from a peptide mimic to an aza-decaline scaffold.
Teruya K; Hattori Y; Shimamoto Y; Kobayashi K; Sanjoh A; Nakagawa A; Yamashita E; Akaji K
Biopolymers; 2016 Nov; 106(4):391-403. PubMed ID: 26572934
[TBL] [Abstract][Full Text] [Related]
9. pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses.
Tan J; Verschueren KH; Anand K; Shen J; Yang M; Xu Y; Rao Z; Bigalke J; Heisen B; Mesters JR; Chen K; Shen X; Jiang H; Hilgenfeld R
J Mol Biol; 2005 Nov; 354(1):25-40. PubMed ID: 16242152
[TBL] [Abstract][Full Text] [Related]
10. Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL Protease.
Hirose Y; Shindo N; Mori M; Onitsuka S; Isogai H; Hamada R; Hiramoto T; Ochi J; Takahashi D; Ueda T; Caaveiro JMM; Yoshida Y; Ohdo S; Matsunaga N; Toba S; Sasaki M; Orba Y; Sawa H; Sato A; Kawanishi E; Ojida A
J Med Chem; 2022 Oct; 65(20):13852-13865. PubMed ID: 36229406
[TBL] [Abstract][Full Text] [Related]
11. A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters.
Verschueren KH; Pumpor K; Anemüller S; Chen S; Mesters JR; Hilgenfeld R
Chem Biol; 2008 Jun; 15(6):597-606. PubMed ID: 18559270
[TBL] [Abstract][Full Text] [Related]
12. Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus.
Goetz DH; Choe Y; Hansell E; Chen YT; McDowell M; Jonsson CB; Roush WR; McKerrow J; Craik CS
Biochemistry; 2007 Jul; 46(30):8744-52. PubMed ID: 17605471
[TBL] [Abstract][Full Text] [Related]
13. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
Akaji K; Konno H
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
[TBL] [Abstract][Full Text] [Related]
14. 1H, 13C and 15N resonance assignments of SARS-CoV main protease N-terminal domain.
Zhang S; Zhong N; Ren X; Jin C; Xia B
Biomol NMR Assign; 2011 Oct; 5(2):143-5. PubMed ID: 21181312
[TBL] [Abstract][Full Text] [Related]
15. From Repurposing to Redesign: Optimization of Boceprevir to Highly Potent Inhibitors of the SARS-CoV-2 Main Protease.
Göhl M; Zhang L; El Kilani H; Sun X; Zhang K; Brönstrup M; Hilgenfeld R
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807537
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies.
Tsai KC; Chen SY; Liang PH; Lu IL; Mahindroo N; Hsieh HP; Chao YS; Liu L; Liu D; Lien W; Lin TH; Wu SY
J Med Chem; 2006 Jun; 49(12):3485-95. PubMed ID: 16759091
[TBL] [Abstract][Full Text] [Related]
17. Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer.
Xu T; Ooi A; Lee HC; Wilmouth R; Liu DX; Lescar J
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2005 Nov; 61(Pt 11):964-6. PubMed ID: 16511208
[TBL] [Abstract][Full Text] [Related]
18. Mutation of Gly-11 on the dimer interface results in the complete crystallographic dimer dissociation of severe acute respiratory syndrome coronavirus 3C-like protease: crystal structure with molecular dynamics simulations.
Chen S; Hu T; Zhang J; Chen J; Chen K; Ding J; Jiang H; Shen X
J Biol Chem; 2008 Jan; 283(1):554-564. PubMed ID: 17977841
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease.
Zhang S; Zhong N; Xue F; Kang X; Ren X; Chen J; Jin C; Lou Z; Xia B
Protein Cell; 2010 Apr; 1(4):371-383. PubMed ID: 21203949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
